In the course of raising high affinity antibodies to penicilloylated bovine Ig (BPO-BGG) in strain 2 guinea pigs by repeated antigenic stimulation over a period of 9 mo, it was observed that one animal from a group of seven no longer gave a delayed hypersensitivity skin response when challenged with BPO-BGG. Further investigation revealed that the serum of this animal (*305) had no detectable antibodies to BPO-BGG but possibly possessed strain-specific antiidiotypic antibodies which specifically suppressed BPO-BGG-induced T-cell proliferation in vitro. The inhibitory activity which was associated with the serum of animal *305 was functionally similar to the strain 2 anti-idiotypic antibodies (~ strain 2 BPO-BGG) raised by immunizing strain 2 guinea pigs with immunoadsorbent column-purified strain 2 BPO-BGG (1). This communication compares the in vitro inhibitory effect of serum *305 with that of ~ strain 2 BPO-BGG antiserum.
site was measured 24 h after testing with a caliper (Schnelltaster; Kroeplin, Schiichtern, Germany). Delayed skin reactivity to BPO-BGG was assessed by the intradermal injection into the shaved flank of 5 and 50 ~g BPO-BGG in 100 ~1 of PBS (0.01 M, pH 7.4).
Production ofAntisera. Strain 13 anti-strain 2 serum was prepared by immunizing strain 13 guinea pigs with a homogenate of strain 13 lymph node and spleen cells as previously described (3) . Antisera against strain 2 and strain 13 anti-BPO-BGG were prepared as previously described (2) . The immune anti-BPO-BGG antibodies were then used as immunogens for the sensitization of strain 2 and strain 13 guinea pigs (1) . Serum *305 was obtained from a strain 2 guinea pig (*305) which had been immunized with BPO-BGG according to the immunization schedule outlined in Table I . All animals Ca total of seven) were bled (6-8 ml blood) at about 2 wk intervals and their serum used for the preparation of anti-BPO-BGG antibody (2) . At the end of day 264 one strain 2 animal out of a group of seven no longer gave a delayed hypersensitivity skin response when challenged with 50 ~g BPO-BGG. The sera of all animals were tested for their ability to inhibit BPO-BGG-induced T-cell proliferation in vitro.
Absorption of Antisera. Antisera were mixed with an equal volume of packed lymph node and spleen cells (approximately 10 ~ cells/ml of serum) for 4 h at 4°C. Each antiserum was absorbed at least three times. The absorbed antisera were centrifuged at 10,00O rpm for 30 min and sterilized by Millipore filtration.
Antibody Determinations. Antibodies directed against the penicilloyl (BPO) group were determined by the neutralization of penicillin-coated T4 bacteriophages as previously described (4) . The passive hemagglutination technique was used to measure antibodies to bovine Ig (BGG) (5) . BGG was bound with carbodiimide to sheep erythrocytes as described by Golub et al. (5) .
Cell Preparation
PERITONEAL EXUDATE LYMPHOCYTES (PEL). Guinea pig PEL were purified by passage through nylon wool columns (2) . For the assay of antigen-induced proliferation, lymphocyte suspensions (20 × 10B/ml) were incubated with either 100 ~g of DNPT-GL and GT or 400 ~g aspiryl ovalbumin (ASP-OVA), BPO-BGG, and iT, G)-A--L/ml of Medium 199 (M-199) containing 10% heat-inactivated fetal calf serum. A portion of the cells was also incubated with 10 ~g phytohemagglutinin (PHA)/ml of M-199. The cells were pulsed with antigen for 30 min at 37°C, washed three times with M-199, and then cultured at a cell concentration of 1.25 × 106/ml. 0.2-ml aliquots of the antigenpulsed PEL (0.25 × 106 cells) were cultured in round-bottom microtiter plates (Cooke Microtiter system; Sterilin LTD, Richmond, Surrey, England) in medium RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) supplemented with penicillin (100 U/ml) and streptomycin (100 ~g/ ml), adding either 1% normal guinea pig serum or 1% guinea pig antiserum supplemented with 9% beat-inactivated fetal calf serum for 72 h at 37°C. 18 h before the termination of the cultures, 0.5 ~Ci of tritiated thymidine (sp act, 5 Ci/mmol; The Radiochemical Centre, Amersham, Great Britain) was added to each well. The cells were harvested with a multiple cell culture harvester (Skatron, Lierbyen, Norway), and the radioactivity was measured in a Beckman liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). The results are expressed as total counts per minute per culture well. (Table I ) over a period of about 9 mo, resulted in one strain 2 guinea pig (out of a group of seven) becoming unresponsive when challenged with BPO-BGG in vivo. Whereas the other members of the group gave intense 4-h Arthus and 24-h delayed skin reactions to 50 ~g of intradermally injected BPO-BGG, animal *305 failed to respond. The skin test was repeated 10 days later with the same results. The serum of animal *305 contained no detectable antibodies to either the BPO group or to the BGG carrier, whereas the sera of the other strain 2 guinea pigs in the group had high antibody titers to both the BPO and the BGG determinants (results not shown). The sera of all animals were then tested for their capacity to inhibit BPO-BGG- induced T-cell proliferation in vitro. As shown in Table II , serum *305 totally suppresses T-cell proliferation, whereas the sera from the other strain 2 guinea pigs which gave strong skin responses to BPO-BGG failed to inhibit lymphocyte proliferation. The results in Table III further show that serum *305 and h strain 2 BPO-BGG (raised by immunizing with syngeneic anti-BPO-BGG;) can both specifically suppress T-cell activation of primed strain 2 PEL but not of strain 13 PEL (Table IV) . Furthermore, the inhibitory activity of serum *305 can only be absorbed by immune cells from strain 2 (Table III) guinea pigs but not by immune cells from strain 13 animals (Table HI) . These data suggest a functional similarity between serum *305 and strain-specific strain 2 BPO-BGG. lar theory based on the interaction of complementary idiotypes has been put forward by KShler et al. (12) . The results in this paper indicate that a serum with specific in vitro inhibitory activity may arise in the course of repeated antigenic stimulation. These data are reminiscent of the production of anti-idiotypic antibody in rats repeatedly immunized with alloantigens (9) . A striking feature of serum *305 however, is that its activity appears to be directed against strain-specific idiotypes characteristic of strain 2 guinea pigs and in this respect serum *305 is functionally similar to ~ strain 2 BPO-BGG produced by repeated immunization with syngeneic antibodies. Both serum *305 and ~ strain 2 BPO-BGG are exquisitely specific in vitro in that they only inhibit BPO-BGG-induced in vitro T-cell proliferation but they do not interfere with the stimulation induced by the other antigens (Table HI ; reference 1).
Results

Repeated immunization with BPO-BGG
The significance of the production of "auto-anti-idiotypic antibodies", specifically reactive with a particular antigen (in one case out of seven), is at present not clear. One possibility is that the production of anti-BPO-BGG may have been suppressed by an excess of complementary (12) anti-idiotypic antibodies with the result that the immune balance in the "suppressed" animal may have been temporarily shifted in the favor of auto-anti-idiotypic antibody production. Further studies with strain 2 guinea pigs using different immunization schedules and monitoring the appearance and disappearance of antibodies and antiidiotypic antibodies may clarify this point.
In support of the suggestion that the auto-anti-idiotypic antibodies (8, 9) , which sometimes appear in the serum of immunologicaily unresponsive animals, may serve an immunoregulatory role is the finding that the in vivo administration of ~ strain 2 BPO-BGG into sensitized strain 2 guinea pigs results in a dramatic but short-lived (about 4 wk) fall in the level of anti-BPO antibodies. 1 It remains to be seen whether further immunization with BPO-BGG can induce unresponsiveness in the remaining responders of the group with the concomitant appearance of "auto-antibody" activity and whether recovery from unresponsiveness results in a decline in the level of BPO-BGG-specific inhibitory activity in the serum of animal *305.
Summary
The in vitro T-cell proliferation induced by penicilloylated bovine IgG (BPO-BGG) in sensitized strain 2 guinea pigs could be specifically blocked by the serum of guinea pig (*305) which had been repeatedly immunized with BPO-BGG over a period of 9 mo. The antibodies which appeared in the serum of this animal (*305) were functionally similar to the strain 2 anti-idiotypic antibodies (~ strain 2 BPO-BGG) raised by immunizing strain 2 guinea pigs with immunoadsorbent column-purified BPO-BGG. Animal *305 had no detectable antibodies to BPO-BGG and failed to give a delayed hypersensitivity skin response when challenged with BPO-BGG.
